Achilles Investment Company Ltd.

Regulatory Filings • Nov 16, 2021

National Storage Mechanism | Additional information

RNS Number : 5670S

abrdn China Investment Company Ltd.

16 November 2021

16 November 2021

abrdn China Investment Company Limited (formerly Aberdeen Emerging Markets Investment Company Limited) ("ACIC" or the "Company")

Legal Entity Identifier (LEI): 213800RIA1NX8DP4P938

Update on Portfolio Allocation

This announcement follows up on the statement made by the Chairman on 9 November 2021 following the completion of the scheme of reconstruction (the "Scheme") of Aberdeen New Thai Investment Trust ("ANW" or "New Thai") that the Company would provide an update on its portfolio allocation in the next few days.

Since the Scheme completed on 9 November over £100m has been invested in Chinese equities, taking the exposure to the country to almost 77% of net assets.  This figure is expected to exceed 90% by the end of November. Uninvested cash currently represents around 10% of net assets.

The Company's portfolio no longer contains any holdings that have been identified as a threat to U.S. national security interests as classified by President Biden's Executive Order (the "Order") 14032 that restricts the purchase or sale by US Persons, of the publicly traded securities of certain Chinese Military Industrial Complex companies ("CMICC"s).

-----Ends-----

Enquiries:

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to the Company)

Evan Bruce-Gardyne/William Hemmings                  Tel +44 (0) 20 7463 6000

PraxisIFM Fund Services (UK) Limited (UK Administration Agent)

Brian Smith                                                                    Tel: +44 (0)204 513 9260

Shore Capital & Corporate Limited (Financial adviser and broker to the Company)

Robert Finlay / Rose Ramsden                                   Tel: +44 (0)20 7601 6115

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDBFBJTMTIBBAB